financetom
Business
financetom
/
Business
/
Ticket reseller StubHub raises about $800 million in US IPO
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Ticket reseller StubHub raises about $800 million in US IPO
Sep 16, 2025 5:33 PM

NEW YORK (Reuters) -Ticket reseller StubHub ( STUB ) on Tuesday priced its initial public offering at $23.50, within its marketed range of $22 to $25 per share, raising about $800 million and setting the stage for its long-awaited stock market debut.

The New York-based company, led by co-founder Eric Baker, sold 34.04 million shares in its IPO, giving StubHub ( STUB ) an $8.6 billion valuation.

StubHub ( STUB ) is leading another busy week for the autumn IPO market, with companies ranging from cybersecurity to e-commerce slated to go public in New York by Friday.

Last week, half a dozen companies led by fintech giant Klarna ( KLAR ) raised more than $4 billion combined, marking the busiest week for the U.S. IPO market since 2021.

StubHub ( STUB ) had paused its IPO plans in April as tariff-driven volatility rattled equities and slammed shut the new listings market.

Founded in 2000, StubHub ( STUB ) operates a ticketing marketplace that enables buyers from over 200 countries to purchase tickets for live events, including sports and music performances.

While its primary focus is on secondary ticketing, StubHub ( STUB ) also offers tickets directly from artists and venues.

Earlier this month, StubHub ( STUB ) announced a multi-year agreement with the Major League Baseball to offer tickets to games.

"Investors will be very keen on its growth plans and the expansion opportunity into original ticket sales is certainly an appealing part of the story," said Matt Kennedy, senior strategist at Renaissance Capital, a provider of IPO-focused research and ETFs.

"For consumers, switching costs are low, but there are still network effects for having the largest ticket marketplaces, with some very strong brand capital."

StubHub ( STUB ) had been eyeing a New York flotation for years, having confidentially filed in 2021 to go public through a direct listing, according to regulatory filings.

The company later abandoned the direct listing plan and opted for a traditional IPO.

StubHub ( STUB ) is set to begin trading on the New York Stock Exchange under the ticker symbol "STUB" on Wednesday. J.P. Morgan and Goldman Sachs were lead joint book-running managers for the offering.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Mirasol Resources Boosts Private Placement Financing to $5 Million from $3 Million
Mirasol Resources Boosts Private Placement Financing to $5 Million from $3 Million
Oct 3, 2024
06:45 AM EDT, 10/03/2024 (MT Newswires) -- Mirasol Resources ( MRZLF ) late on Wednesday said that due to strong demand it increased its non-brokered private placement to 11.1 million units at a price of $0.45 per unit to raise up to $5 million, up from an original plan to raise $3 million. Proceeds from the private placement will be...
Market Chatter: OpenAI Asks Investors to Refrain Bankrolling Other AI Rivals
Market Chatter: OpenAI Asks Investors to Refrain Bankrolling Other AI Rivals
Oct 3, 2024
06:43 AM EDT, 10/03/2024 (MT Newswires) -- Microsoft ( MSFT )-backed (MSFT) OpenAI is asking its financiers to refrain from backing five competitors, Reuters reported Wednesday, citing unnamed sources. Among those targeted by OpenAI are Amazon ( AMZN )-backed (AMZN) Anthropic, Elon Musk's xAI, Safe Superintelligence, Perplexity, and Glean, Reuters said. The report said the request is not legally binding....
Eli Lilly's Tirzepatide Injection No Longer in Shortage in US, FDA Says
Eli Lilly's Tirzepatide Injection No Longer in Shortage in US, FDA Says
Oct 3, 2024
06:50 AM EDT, 10/03/2024 (MT Newswires) -- Eli Lilly's ( LLY ) tirzepatide injection is no longer considered to be in short supply in the US, the US Food and Drug Administration said in a notice Wednesday. Tirzepatide injection had been in shortage since 2022 due to higher demand, the FDA added. The FDA said that the regulator confirmed with...
Market Chatter: Department of Justice Expands Probe-Fixing Probe Into SAP's Dealings With 94 Civilian Government Agencies
Market Chatter: Department of Justice Expands Probe-Fixing Probe Into SAP's Dealings With 94 Civilian Government Agencies
Oct 3, 2024
06:51 AM EDT, 10/03/2024 (MT Newswires) -- The US Department of Justice has reportedly expanded its investigation into potential price-fixing involving SAP (SAP) and software reseller Carahsoft Technology, Bloomberg reported Thursday, citing new court filings. This probe, initially focused on whether these companies overcharged the US military and certain government agencies for more than $2 billion in SAP technology products...
Copyright 2023-2026 - www.financetom.com All Rights Reserved